decreased susceptibility to pharmacologically induced seizures_Slc4a10<tm1.1Cahb>/Slc4a10<tm1.1Cahb>

http://metadb.riken.jp/0002887I129S1Sv129X1SvJC57BL6Slc4a10tm11CahbSlc4a10tm11CahbSlc4a10tm11Cahb

decreased susceptibility to pharmacologically induced seizures_Slc4a10<tm1.1Cahb>/Slc4a10<tm1.1Cahb>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• solute carrier family 4, sodium bicarbonate cotransporter-like, member 10
  http://metadb.riken.jp/db/mgi_rdf/MGI:2150150

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Slc4a10<tm1.1Cahb>/Slc4a10<tm1.1Cahb>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Slc4a10<tm1.1Cahb>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S1/Sv * 129X1/SvJ * C57BL/6

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• decreased susceptibility to pharmacologically induced seizures
  http://purl.obolibrary.org/obo/MP_0002887

文献

http://purl.org/net/cito/citesAsAuthority

• Stefan. Jacobs, et.al., Mice with targeted Slc4a10 gene disruption have small brain ventricles and show reduced neuronal excitability., Proceedings of the National Academy of Sciences of the United States of America, 2008, 105
  http://rdf.ncbi.nlm.nih.gov/pubmed/18165320